CN110403890A - 包括鲟鱼卵提取物和鲟鱼羊水提取物的用于皮肤美容的组合物 - Google Patents
包括鲟鱼卵提取物和鲟鱼羊水提取物的用于皮肤美容的组合物 Download PDFInfo
- Publication number
- CN110403890A CN110403890A CN201910347747.7A CN201910347747A CN110403890A CN 110403890 A CN110403890 A CN 110403890A CN 201910347747 A CN201910347747 A CN 201910347747A CN 110403890 A CN110403890 A CN 110403890A
- Authority
- CN
- China
- Prior art keywords
- sturgeon
- skin
- amniotic fluid
- fluid extract
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000284 extract Substances 0.000 title claims abstract description 102
- 241000881711 Acipenser sturio Species 0.000 title claims abstract description 90
- 239000000203 mixture Substances 0.000 title claims abstract description 49
- 210000004381 amniotic fluid Anatomy 0.000 title claims abstract description 44
- 230000009759 skin aging Effects 0.000 claims abstract description 14
- 238000002360 preparation method Methods 0.000 claims description 15
- 239000002537 cosmetic Substances 0.000 claims description 13
- 230000037303 wrinkles Effects 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 102000011690 Adiponectin Human genes 0.000 claims description 10
- 108010076365 Adiponectin Proteins 0.000 claims description 10
- 210000001789 adipocyte Anatomy 0.000 claims description 10
- 230000014509 gene expression Effects 0.000 claims description 9
- 230000004069 differentiation Effects 0.000 claims description 7
- 210000000130 stem cell Anatomy 0.000 claims description 7
- 230000036541 health Effects 0.000 claims description 5
- 239000008194 pharmaceutical composition Substances 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims description 3
- 235000013376 functional food Nutrition 0.000 claims description 3
- 230000037380 skin damage Effects 0.000 claims description 2
- 239000000469 ethanolic extract Substances 0.000 claims 1
- 208000028990 Skin injury Diseases 0.000 abstract description 9
- 230000006872 improvement Effects 0.000 abstract description 4
- 210000003491 skin Anatomy 0.000 description 36
- 210000004027 cell Anatomy 0.000 description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 18
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 15
- 238000000605 extraction Methods 0.000 description 15
- 230000000052 comparative effect Effects 0.000 description 14
- 239000003795 chemical substances by application Substances 0.000 description 13
- 235000019441 ethanol Nutrition 0.000 description 13
- 239000006210 lotion Substances 0.000 description 12
- 206010040954 Skin wrinkling Diseases 0.000 description 11
- 239000006071 cream Substances 0.000 description 11
- 238000000034 method Methods 0.000 description 11
- 102000002322 Egg Proteins Human genes 0.000 description 10
- 108010000912 Egg Proteins Proteins 0.000 description 10
- 210000004681 ovum Anatomy 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- 235000019197 fats Nutrition 0.000 description 9
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 8
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 239000000654 additive Substances 0.000 description 6
- 230000000996 additive effect Effects 0.000 description 6
- 230000032683 aging Effects 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- GXPHKUHSUJUWKP-UHFFFAOYSA-N troglitazone Chemical compound C1CC=2C(C)=C(O)C(C)=C(C)C=2OC1(C)COC(C=C1)=CC=C1CC1SC(=O)NC1=O GXPHKUHSUJUWKP-UHFFFAOYSA-N 0.000 description 6
- 229960001641 troglitazone Drugs 0.000 description 6
- GXPHKUHSUJUWKP-NTKDMRAZSA-N troglitazone Natural products C([C@@]1(OC=2C(C)=C(C(=C(C)C=2CC1)O)C)C)OC(C=C1)=CC=C1C[C@H]1SC(=O)NC1=O GXPHKUHSUJUWKP-NTKDMRAZSA-N 0.000 description 6
- 230000003796 beauty Effects 0.000 description 5
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 239000002953 phosphate buffered saline Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- 235000013361 beverage Nutrition 0.000 description 4
- 239000002552 dosage form Substances 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 230000006698 induction Effects 0.000 description 4
- 230000001939 inductive effect Effects 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- NPGIHFRTRXVWOY-UHFFFAOYSA-N Oil red O Chemical compound Cc1ccc(C)c(c1)N=Nc1cc(C)c(cc1C)N=Nc1c(O)ccc2ccccc12 NPGIHFRTRXVWOY-UHFFFAOYSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 239000001569 carbon dioxide Substances 0.000 description 3
- 229910002092 carbon dioxide Inorganic materials 0.000 description 3
- 238000004043 dyeing Methods 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 230000001815 facial effect Effects 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 239000000314 lubricant Substances 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 230000003020 moisturizing effect Effects 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 239000013641 positive control Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 150000005846 sugar alcohols Polymers 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 239000007767 bonding agent Substances 0.000 description 2
- 244000309466 calf Species 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 238000005194 fractionation Methods 0.000 description 2
- 238000009499 grossing Methods 0.000 description 2
- 238000003306 harvesting Methods 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000008108 microcrystalline cellulose Substances 0.000 description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- 235000012149 noodles Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 2
- 239000003002 pH adjusting agent Substances 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 235000008373 pickled product Nutrition 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000013049 sediment Substances 0.000 description 2
- 230000036560 skin regeneration Effects 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 239000011343 solid material Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 235000012222 talc Nutrition 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 239000000892 thaumatin Substances 0.000 description 2
- 235000010436 thaumatin Nutrition 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- APIXJSLKIYYUKG-UHFFFAOYSA-N 3 Isobutyl 1 methylxanthine Chemical compound O=C1N(C)C(=O)N(CC(C)C)C2=C1N=CN2 APIXJSLKIYYUKG-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 241000790917 Dioxys <bee> Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 206010024438 Lichenification Diseases 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010039792 Seborrhoea Diseases 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 235000006092 Stevia rebaudiana Nutrition 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 229920000180 alkyd Polymers 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 210000001217 buttock Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- ARQRPTNYUOLOGH-UHFFFAOYSA-N chcl3 chloroform Chemical compound ClC(Cl)Cl.ClC(Cl)Cl ARQRPTNYUOLOGH-UHFFFAOYSA-N 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229940099112 cornstarch Drugs 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 230000008921 facial expression Effects 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- -1 hydroxy-propyl Chemical group 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 239000001023 inorganic pigment Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000012860 organic pigment Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 235000013550 pizza Nutrition 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 208000008742 seborrheic dermatitis Diseases 0.000 description 1
- 235000004400 serine Nutrition 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 238000007614 solvation Methods 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 238000000194 supercritical-fluid extraction Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/204—Animal extracts
- A23V2250/2042—Marine animal, fish extracts
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Polymers & Plastics (AREA)
- Zoology (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Marine Sciences & Fisheries (AREA)
- Food Science & Technology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Cosmetics (AREA)
Abstract
提供一种包括鲟鱼卵提取物和鲟鱼羊水提取物的组合物。所述组合物可有效地用于皮肤美容、皮肤损伤或皮肤老化的改善及治疗等。
Description
技术领域
本发明涉及一种用于皮肤美容的组合物。
背景技术
在现代社会中,紧致的面部是童颜和健康的象征。许多女性希望以各种方法增加面部饱满丰润度和弹性,并且已经正积极地进行涉及对皮肤美容有用的材料和成分的研究。
一方面,鱼子酱(caviar)是鲟鱼卵加盐的腌制品,是众所周知的被称为世界三大珍味的高级食材。它不仅富含蛋白质、脂肪、糖、维生素等的各种营养素以及如亮氨酸和精氨酸等的必需氨基酸,更富含谷氨酸、丝氨酸和丙氨酸等各种氨基酸。此外,鱼子酱中含有的脂肪主要由胆固醇和卵磷脂组成,并起到再生表皮脂质膜的作用,而丰富的奥米茄-3(omega-3)脂肪酸具有抗衰老效果。因此,一些化妆品包括鱼子酱。
然而,鲟鱼羊水的效果仍然不太知名,而且,鲟鱼卵提取物和鲟鱼羊水提取物的混合物对皮肤美容改善的效果仍然没有人知道。
发明内容
本公开的一方面提供了一种包括鲟鱼卵提取物和鲟鱼羊水提取物的用于皮肤美容的化妆品组合物。
本公开的另一方面提供了一种包括鲟鱼卵提取物和鲟鱼羊水提取物的用于皮肤美容的保健功能食品的组合物。
本公开的另一方面提供了一种包括鲟鱼卵提取物和鲟鱼羊水提取物的用于预防或治疗皮肤皱纹或皮肤老化的药物组合物。
本公开的另一方面提供了包含鲟鱼卵提取物和鲟鱼羊水提取物的组合物在制备用于皮肤美容的化妆品中的用途。
本公开的另一方面提供了包含鲟鱼卵提取物和鲟鱼羊水提取物的组合物在制备用于预防或治疗皮肤损伤、皮肤皱纹或皮肤老化的药剂中的用途。
本公开的一方面提供了一种包括鲟鱼卵提取物和鲟鱼羊水提取物的用于改善皮肤状况的化妆品组合物。本公开的另一方面提供了一种包括鲟鱼卵提取物和鲟鱼羊水提取物的用于改善皮肤美容的保健功能食品的组合物。本公开的另一方面提供了一种包括鲟鱼卵提取物和鲟鱼羊水提取物的用于预防或治疗皮肤损伤或皮肤老化的药物组合物。本公开的另一方面提供了包含鲟鱼卵提取物和鲟鱼羊水提取物的组合物在制备用于皮肤美容的化妆品中的用途。本公开的另一方面提供了包含鲟鱼卵提取物和鲟鱼羊水提取物的组合物在制备用于预防或治疗皮肤损伤、皮肤皱纹或皮肤老化的药剂中的用途。
在本公开中,术语“鱼子酱”不仅用于表示鲟鱼卵加盐的腌制品,还包括天然鲟鱼卵和其所有加工产品。因此,“鱼子酱”可与“鲟鱼卵”互换使用。一方面,鲟鱼羊水可以通过使用在不切开鲟鱼肚子的情况下挤压出鲟鱼卵以从鲟鱼采获鱼卵的方法时获得。所述鲟鱼卵和鲟鱼羊水可以直接从鲟鱼中采获,或者通过购买商业销售的产品轻松能够获得。
术语“皮肤美容”是指以皮肤皱纹改善、体积增强,弹性改善或皮肤再生等方法将因皮肤损伤或皮肤老化而受损的皮肤恢复到皮肤受损之前的状态。所述皮肤包括身体的所有部位,包括面部、手部、手臂、腿部、脚部、胸部、腹部、背部、臀部和头皮。
术语“皮肤损伤”是包括皮肤组织或细胞的临床和美容观点上的损伤,其包括外部物理损伤、化学物质、细菌、真菌和病毒等的渗透、暴露在紫外线下、皮肤水分流失、老化引起的皱纹、自由基(活性氧)引起的氧化、皮肤色素沉着、皮肤炎症、脂溢性皮炎、发红(红肿和红斑)、浮肿、苔藓样硬化、湿疹、瘙痒感(瘙痒)和特应性皮炎。
术语“皮肤老化”包括随时间的内源性老化和外部环境引起的外源性老化。所述皮肤老化可以包括皮肤皱纹、斑痕和痣等。所述皮肤皱纹可以是由于皮肤衰老而产生的细线条纹。皮肤皱纹可以是由光老化、年龄、面部表情、水分不足或其组合而引起。所述光老化可以通过暴露于紫外线(包括UVA、UVB和UVC)而使皮肤老化。所述皮肤皱纹改善可以抑制或阻碍皮肤皱纹的产生,或者缓和已经形成的皱纹。
所述提取物可以使用水、丙酮、醇,例如C1-C6醇、C3-C6多元醇或其混合物作为溶剂来提取。所述C1-C6醇包括甲醇、乙醇、丙醇、异丙醇、1,3-丙二醇、丁醇、戊醇或己醇。所述溶剂可以是例如水和醇的混合物,即醇水溶液。醇水溶液的醇浓度可以是1(w/w)%至100(w/w)%,例如,10(w/w)%至90(w/w)%、20(w/w)%至90(w/w)%、30(w/w)%至90(w/w)%、40(w/w)%至90(w/w)%、50(w/w)%至90(w/w)%、60(w/w)%至80(w/w)%,或70(w/w)%。所述醇水溶液可以是甲醇、乙醇或丁醇水溶液。另外,所述提取物可以以1∶1至1∶20、1∶5至1∶15,或1∶8至1∶12的浓度与水混合。例如,所述鲟鱼卵提取物可以用60(w/w)%至80(w/w)%的醇水溶液来提取,所述鲟鱼羊水提取物可以以1∶1至1∶20、1∶5至1∶15,或1∶8至1∶12的浓度与水混合。
所述鲟鱼卵提取物和鲟鱼羊水提取物的混合比例可以是例如1∶0.25至1∶4、1∶0.8至1∶1.2,或1∶1。当鲟鱼卵提取物和鲟鱼羊水提取物的混合比例小于上述范围或超过上述范围时,存在不会产生根据鲟鱼卵提取物和鲟鱼羊水提取物结合的协同效应的问题。
所述提取物可以通过本领域的常规方法来提取,例如,加温提取、加压提取、超声波提取、热水提取、回流冷却提取、亚临界提取或超临界提取。
所述提取可以在4℃至70℃的温度下进行,例如在以下温度下进行:4℃至50℃、4℃至40℃、4℃至30℃、10℃至70℃、15℃至70℃、20℃至70℃、4℃至50℃、10℃至50℃、4℃至40℃、4℃至30℃、10℃至40℃、10℃至35℃,或10℃至30℃,或室温。所述提取时间可以根据所选温度和提取方法而不同,例如可以是1小时至3天、1小时至2天、1小时至1天、5小时至3天、5小时至2天、5小时至1天、10小时至3天、15小时至2天、15小时至36小时、18小时至30小时、1天至3天、1天至2天,或24小时。例如,可以将提取原料在室温下浸入提取溶剂中12小时至48小时,然后进行超声波提取1小时至8小时。
所述提取可以重复一次或以上,例如可以重复一次至五次,每次提取可以以相同方法或以不同方法进行。所述提取可以进一步包括通过已知方法如过滤分离残余物和提取物的过程。所述提取还可以包括通过如在减压下浓缩的已知方法从所得提取物中除去溶剂。所述提取还可以对所得提取物进行包括如氮气干燥或冻结干燥的干燥来制备干燥的提取物。所述提取物可以是浓缩液的形式,或者在干燥后根据需要使用如二甲基亚砜(DMSO)等适当的溶剂再次溶剂化的形式,或通过冻结干燥的粉末形式。
所述组合物可进一步包括所述提取物的馏分。馏分(fraction)是指所述提取物被分成其一部分的成分的物质,即即分馏(fractionation)物质,并且可以根据本领域公知的方法通过分馏获得。
所述组合物可以包括基于组合物的总重量的以下重量百分比的鲟鱼卵提取物或鲟鱼羊水提取物:0.001重量百分比至80重量百分比、0.01重量百分比至60重量百分比、0.01重量百分比至40重量百分比、0.01重量百分比至30重量百分比、0.01重量百分比至20重量百分比、0.01重量百分比至10重量百分比、0.01重量百分比至5重量百分比、0.05重量百分比至60重量百分比、0.05重量百分比至40重量百分比、0.05重量百分比至30重量百分比、0.05重量百分比至20重量百分比、0.05重量百分比至10重量百分比、0.05重量百分比至5重量百分比、0.1重量百分比至60重量百分比、0.1重量百分比至40重量百分比、0.1重量百分比至30重量百分比、0.1重量百分比至20重量百分比、0.1重量百分比至10重量百分比,或0.1重量百分比至5重量百分比。当小于在上述范围内的0.001重量百分比时,皮肤美容效果可能变弱而并不优选,当超过80重量百分比时,在经济学方面或制备制剂方面并不优选。
所述提取物可以是在分别提取鲟鱼卵和鲟鱼羊水的单独提取物后混合的提取物,或者可以是鲟鱼卵和鲟鱼羊水的混合物的提取物。当分别单独提取鲟鱼卵和鲟鱼羊水时,分别可以使用相同或不同的提取方法和提取条件。提取的鲟鱼卵和鲟鱼羊水,或其提取物的重量比可根据目的而适当调整。例如,鲟鱼卵提取物与鲟鱼羊水提取物的比例可以是1∶0.5至2、1∶0.7至1.5,或1∶0.9至1.1。
所述组合物可以根据其用途包括提取物作为有效量或有效成分。所述有效量可以根据个体而适当选择。所述有效量可以根据包括以下项的因素以及在生理至医学领域中熟知的其他因素来决定:疾病至疾病状况的严重程度、个体的年龄、体重、健康、性别、个体的对提取物的敏感度、施用时间、施用途径和排出比率、施用期间、与所述组合物配合或同时使用的其他组合物。
当所述组合物是化妆品组合物时,提取物可制备为包括以下的剂型:化妆水(润肤液)、柔肤水、爽肤水、收敛剂(Astringent)、乳液、牛奶润肤露(milk lotion)、保湿乳液、营养液、按摩霜、营养霜、保湿霜、手霜、粉底、精华、营养精华、膜、肥皂、洁面泡沫、洁面乳、洁面霜、身体乳液、身体清洁液、悬浮液、凝胶、粉末、粘膏(paste)、面膜或片装面膜或喷雾组合物。可根据本领域常规方法制备此类剂型的组合物。所述化妆品组合物可以进一步包括保存剂、稳定剂、表面活性剂、溶剂、保湿剂、润肤剂、紫外线吸收剂、防腐剂、杀菌剂、抗氧化剂、pH调节剂、有机和无机颜料、香料、冷感剂或止汗剂。在不损害本发明的目的和效果的范围内,本领域技术人员可以容易地选择诸如上述保湿剂等的附加成分的混合量,该混合量可以是基于组合物的总重量的0.001重量百分比至5重量百分比,具体而言,0.01重量百分比至3重量百分比。
所述提取物可以是用于皮肤美容、预防或改善皮肤损伤的外用剂组合物。所述皮肤外用剂组合物可以制备成本领域常规制备的任何制剂,例如,乳液(emulsion)、面霜、化妆水,乳液、面膜、粉底、乳液(lotion)、美容液和头发化妆品等。具体而言,所述皮肤外用剂组合物可以包括以下制剂:润肤液、柔肤水、爽肤水、收敛剂、乳液、牛奶润肤露、保湿乳液、营养液、按摩霜、营养霜、保湿霜、手霜、粉底、精华、营养精华、膜、肥皂、洁面泡沫、洁面乳、洁面霜、身体乳液和身体清洁液。
当所述组合物是保健食品组合物时,可以制备成本领域已知的常规保健食品的剂型。所述保健食品组合物可以制备为如散剂、颗粒剂、片剂、丸剂、胶囊剂、悬浮液、油剂、糖浆剂、浸渍剂、液剂、萃取剂等的一般剂型,并制备为肉类、香肠、面包、巧克力、糖果类、零食类、饼干类、比萨饼、拉面、其他面类、口香糖类、果冻、包括冰淇淋类的乳制品、各种汤、饮料、茶、饮剂、酒精饮料和维生素复合物的等任意的保健食品形式。为了将所述保健食品制成制剂,可以使用食品学上可接受的载体或添加剂,并且可以将本领域已知的任何载体或添加剂用于制备想要制备的剂型。作为所述添加剂,可以含有各种营养剂、维生素、电解质、调味剂、着色剂、果胶酸及其盐、藻酸及其盐、有机酸、保护性胶体增稠剂、pH调节剂、稳定剂、防腐剂、甘油、醇、用于碳酸饮料的碳酸化剂等。此外,所述添加剂可以含有用于制备天然果汁、果汁饮料和蔬菜饮料的果肉。这些添加剂成分可以单独使用或组合使用,添加剂的比例可以为基于组合物的总重量的0.001重量百分比至5重量百分比,具体地,0.01重量百分比至3重量百分比。
所述保健食品组合物的所述提取物的含量可以根据使用目的(预防或改善)来适当地决定。通常,可以包括食品总重量的0.01重量百分比至15重量百分比,当作为饮料制造时,以100mL为基准,可以含有0.02g至10g的比例,具体地,0.3g至1g的比例。所述饮料可以进一步包括所述提取物之外的其他成分,并且可以进一步包括通常用于饮料的各种香料或天然碳水化合物等。所述天然碳水化合物可以含有如单糖类(例如葡萄糖、果糖等)、二糖类(例如麦芽糖、蔗糖等)、多糖类(例如糊精、环式糊精等)的常规糖以及木糖醇、山梨糖醇、赤藓糖醇等的糖醇。另外,香料可以含有天然香料(例如:奇异果甜蛋白(Thaumatin)、甜叶菊提取物等)及合成香料(例如:糖精、阿斯巴甜等)。所述天然碳水化合物的比例通常为每100mL饮料约1g至20g,具体地,约5g至12g。
当所述组合物是药物组合物时,可以包括药学上可接受的稀释剂或载体。所述稀释剂可以是乳糖、玉米淀粉、大豆油、微晶纤维素或甘露糖醇,润滑剂可以是硬脂酸镁,滑石或其组合。所述载体可以是赋形剂、崩解剂、结合剂、润滑剂或其组合。所述赋形剂可以是微晶纤维素、乳糖、低取代羟基纤维素或其组合。所述崩解剂可以是羟甲基纤维素钙、淀粉乙醇酸钠、无水磷酸氢钙或其组合。所述结合剂可以是聚乙烯吡咯烷酮、低取代羟丙基纤维素、羟丙基纤维素或其组合。所述润滑剂可以是硬脂酸镁、二氧化硅、滑石或其组合。
本发明人在使用鲟鱼卵提取物和鲟鱼羊水提取物的试验中,确认了显着促进脂肪前体细胞向脂肪细胞的分化,以及脂联素的表达水平显着增加。
脂联素(adiponectin)是脂肪细胞在分化期间分泌的脂肪因子。脂联素在人体内诱导各种反应,有助于通过促进皮肤中角质细胞的增殖和迁移来治疗伤口,通过增加胶原蛋白合成来抑制衰老,以及通过增加透明质酸的合成来增强屏障。另外,已知在敏感性皮肤的患者中,脂联素的表达减少,导致疼痛传递物质的表达增加。加上,由于脂肪细胞在皮肤组织的再生中起主要作用,因此将脂肪干细胞和脂肪细胞移植到皮肤中用于皮肤再生的技术是众所周知的。
因此,包括鲟鱼卵提取物和鲟鱼羊水提取物的组合物可有效地用于改善和治疗皮肤美容、皮肤损伤或皮肤老化。
有益效果
包括鲟鱼卵提取物和鲟鱼羊水提取物的组合物可有效地用于改善和治疗皮肤美容、皮肤损伤或皮肤老化。
附图说明
图1显示鲟鱼卵提取物、鲟鱼羊水提取物和其混合提取物的脂联素增加的效果。
具体实施方式
本发明将参考实施例以详细描述下文。然而,这些实施例旨在描述本发明,本发明的范围不限于下面描述的实施例。
比较例1.鱼子酱提取物的制备
通过从国内鲟鱼养殖公司ALMAS CAVIAR购入鱼子酱,并制备了鱼子酱提取物。为了制备鱼子酱提取物,将100g鱼子酱放入1L含70%乙醇的溶液中,然后在室温下密封72小时。用威迪文(Waterman)滤纸在减压下过滤提取液,然后除去固体材料,并将剩余的提取液在配备有冷凝器的真空旋转蒸馏装置中进行浓缩。然后悬浮在1L蒸馏水中,为了进行灭菌,并使用0.2μm注射器过滤器进行了灭菌。
比较例2.鲟鱼羊水提取物的制备
为了制备鲟鱼羊水提取物,将100g鲟鱼羊水(ALMAS CAVIAR)在减压下通过威迪文滤纸过滤以除去固体材料,然后在室温下悬浮在1L蒸馏水中24小时,为了进行灭菌,并使用0.2μm注射器过滤器进行了灭菌。
实施例1.鱼子酱和鲟鱼羊水混合提取物的制备
将所述比较例1和2中获得的鱼子酱提取物和鲟鱼羊水提取物以1∶1的比例混合,并用于以下试验例中。
试验例1.确认在脂肪干细胞中的分化诱导
从美国模式培养物集存库(ATCC)购入成为脂肪细胞之前的一种干细胞3T3-L1细胞,并在加入了10%小牛血清(BCS,美国)的DMEM培养基(美国)上在37℃和5%二氧化碳的條件下进行培养。然后,使用3T3-L1细胞测量比较例1、比较例2和实施例1的提取物的脂肪分化诱导效果,并将脂肪分化诱导效果与1μM被称为脂肪诱导物质的曲格列酮(TR0)进行比较以比较脂肪诱导效果。
具体而言,如下。
将3T3-L1细胞稀释至1X 105个细胞/孔的浓度,并将细胞分株到6孔板中后培养。培养2天后,当细胞生长到约80%程度时,将培养基替换成分化诱导培养基(DMEM,10%胎牛血清((FBS),美国)、1μM地塞米松(Sigma Co.,美国)、0.mM 5甲基异丁基黄嘌呤(IBMX,Sigma,美国)、胰岛素(Sigma,美国)),并将干细胞分化为脂肪细胞。在试验组的情況下,在诱导脂肪细胞分化时,对实施例1、比较例1和比较例2分别以1%的浓度进行处理后,在37℃和5%二氧化碳的條件下进行培养。
在开始诱导分化后14天,除去细胞培液,并用磷酸盐缓冲盐水(PBS)洗涤细胞,然后用10%福尔马林处理0.5ml/孔以固定细胞。用60%异丙醇洗涤固定的细胞,并完全干燥。然后,将溶解了油红O(Oil Red-O)在60%异丙醇中的染色液以1ml/孔进行处理,并将脂肪细胞中的脂质体进行染色10分钟。然后,为了确认染色脂肪的含量,加入100%异丙醇并将混合物搅拌10分钟以溶出在中性脂肪中渗出的油红O。将溶出的溶液转移到1.5ml微量管中,并在20℃下以10,000×g进行离心,然后将200μl上清液转移至96孔ELISA板中,并在510nm波长下测量吸光度。结果如下表1所示。
【表1】
内容 | 油红O染色率(%) |
无处理组 | 100% |
曲格列酮0.1μM | 433.1% |
比较例1(1%) | 360.1% |
比较例2(1%) | 339.4% |
实施例1(1%) | 422.5% |
如表1所示,可以确认到与处理比较例1和2的提取物的情况相比,当处理实施例1的混合提取物时的吸光度增加,特别是显示了与用作阳性对照组的曲格列酮类似的吸光度。因此,可以确认实施例1的混合提取物显着促进脂肪干细胞向脂肪细胞的分化。
试验例2.确现对在脂肪干细胞中的脂联素表达量的效果
将3T3-L1细胞(ATCC,美国)在加入了10%小牛血清(BCS,美国)的DMEM培养基(美国)上在37℃和5%二氧化碳的條件下进行培养。此后,使用3T3-L1细胞测量比较例1、比较例2和实施例1的提取物的脂联素表达量,并使用1μM的曲格列酮作为阳性对照组。具体而言,如下。
将3T3-L1细胞稀释至1X 105个细胞/孔的浓度,并将细胞分株到6孔板中后培养24小时。然后,对实施例1、比较例1和比较例2分别以1%的浓度进行处理后,在37℃和5%二氧化碳的條件下进行培养24小时。用磷酸盐缓冲盐水洗涤培养的细胞,并加入1ml Trizol试剂回收细胞。加入0.2ml氯仿(Chloroform)(1/5比例的Trizol试剂)进行涡流(voltexing)处理,并在通过在4℃下以14,000rpm进行离心15分钟来获得上清液。向上清液加入0.5ml异丙醇,并在进行反应10分钟后,以14000rpm进行离心15分钟来获得沉淀物。除去上清液并用200μl 100%乙醇(EtOH)洗涤两次。然后将沉淀物在室温下完全干燥后,溶解在20μl至30μlDEPC水中。将溶解在DEPC中的RNA定量,并使用每组相同量的RNA合成cDNA。使用作为花青染料的赛博格林(SYBR Green master mix)以合成的cDNA为靶标进行实时聚合酶链反应(PCR),以最终评价脂联素的基因表达程度。
结果如图1所示。如图1所示,可以确认与单独处理的比较例1和2相比,当处理实施例1的提取物时的表达水平有显着增加,并显示出比用作阳性对照组的曲格列酮有更高的表达增加。
Claims (9)
1.一种用于皮肤美容的化妆品组合物,其包括鲟鱼卵提取物和鲟鱼羊水提取物。
2.根据权利要求1所述的化妆品组合物,其中,所述鲟鱼卵提取物是60(w/w)%至80(w/w)%的乙醇提取物。
3.根据权利要求1所述的化妆品组合物,其中,所述鲟鱼羊水提取物与水以1∶8至1∶12(w/w)的浓度混合。
4.根据权利要求1所述的化妆品组合物,其中,所述鲟鱼卵提取物和鲟鱼羊水提取物增加脂肪干细胞向脂肪细胞的分化或脂联素的表达量。
5.根据权利要求1所述的化妆品组合物,其中,所述鲟鱼卵提取物和鲟鱼羊水提取物以1∶0.25至1∶4的比例混合。
6.一种用于皮肤美容的保健功能食品的组合物,其包括鲟鱼卵提取物和鲟鱼羊水提取物。
7.一种用于预防或治疗皮肤皱纹或皮肤老化的药物组合物,其包括鲟鱼卵提取物和鲟鱼羊水提取物。
8.一种包含鲟鱼卵提取物和鲟鱼羊水提取物的组合物在制备用于皮肤美容的组合物中的用途。
9.一种包含鲟鱼卵提取物和鲟鱼羊水提取物的组合物在制备用于预防或治疗皮肤损伤、皮肤皱纹或皮肤老化的药剂中的用途。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2018-0050134 | 2018-04-30 | ||
KR1020180050134A KR20190132705A (ko) | 2018-04-30 | 2018-04-30 | 철갑상어 알 및 철갑상어 양수 추출물을 포함하는 피부 미용을 위한 조성물 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110403890A true CN110403890A (zh) | 2019-11-05 |
Family
ID=68357742
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910347747.7A Pending CN110403890A (zh) | 2018-04-30 | 2019-04-26 | 包括鲟鱼卵提取物和鲟鱼羊水提取物的用于皮肤美容的组合物 |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR20190132705A (zh) |
CN (1) | CN110403890A (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102650644B1 (ko) * | 2021-09-15 | 2024-03-26 | 코스맥스 주식회사 | 플라즈마 처리된 캐비어의 아임계수 추출물을 포함하는 화장료 조성물 |
WO2024136513A1 (ko) * | 2022-12-23 | 2024-06-27 | 주식회사 에셀바이오팜 | 철갑상어 점액질을 유효성분으로 포함하는 발모 촉진용 조성물 |
KR20240100757A (ko) * | 2022-12-23 | 2024-07-02 | 순천향대학교 산학협력단 | 철갑상어 점액질을 유효성분으로 포함하는 상처 치유 또는 여드름 치료용 조성물 |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2018849A2 (de) * | 2007-07-26 | 2009-01-28 | Monika Hönscher-Sickert | Kosmetisches Verfahren zur Beeinflussung der Haut |
KR20130088997A (ko) * | 2012-02-01 | 2013-08-09 | 주식회사 유로코스텍 | 생캐비어 추출물 및 발효추출물을 이용한 육모, 발모, 탈모방지 및 두피 개선용 화장료 조성물 |
KR101521268B1 (ko) * | 2013-11-26 | 2015-05-19 | 김기환 | 철갑상어의 양수 발효 조성물의 제조방법, 이로부터 수득되는 철갑상어의 양수 발효 조성물 및 이를 포함하는 화장료 조성물 |
CN104721116A (zh) * | 2015-02-12 | 2015-06-24 | 宝健(北京)生物技术有限公司 | 一种具有抗衰老功效的组合物及其制备方法和应用 |
CN105849323A (zh) * | 2013-10-28 | 2016-08-10 | 多茨设备公司 | 过敏原检测 |
CN106361678A (zh) * | 2016-11-10 | 2017-02-01 | 康美氏(厦门)生物科技有限公司 | 一种具有皮肤抗衰老功效的组合物及该组合物在化妆品中的应用 |
CN106420404A (zh) * | 2015-08-12 | 2017-02-22 | 科丝美诗(中国)化妆品有限公司 | 具有抗氧化效果的发酵植物性油脂化妆品组合物 |
CN107536757A (zh) * | 2017-09-15 | 2018-01-05 | 广州赛莱拉干细胞科技股份有限公司 | 一种防止皮肤老化的组合物及含有该组合物的护肤品 |
KR20180018055A (ko) * | 2016-08-12 | 2018-02-21 | 한국국제대학교 산학협력단 | 철갑상어 유래 유용물질을 포함하는 주름개선 화장료 조성물, 그 유용물질의 수득방법과 그 유용물질을 이용한 주름개선 화장품 제조방법 |
-
2018
- 2018-04-30 KR KR1020180050134A patent/KR20190132705A/ko active Search and Examination
-
2019
- 2019-04-26 CN CN201910347747.7A patent/CN110403890A/zh active Pending
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2018849A2 (de) * | 2007-07-26 | 2009-01-28 | Monika Hönscher-Sickert | Kosmetisches Verfahren zur Beeinflussung der Haut |
KR20130088997A (ko) * | 2012-02-01 | 2013-08-09 | 주식회사 유로코스텍 | 생캐비어 추출물 및 발효추출물을 이용한 육모, 발모, 탈모방지 및 두피 개선용 화장료 조성물 |
CN105849323A (zh) * | 2013-10-28 | 2016-08-10 | 多茨设备公司 | 过敏原检测 |
KR101521268B1 (ko) * | 2013-11-26 | 2015-05-19 | 김기환 | 철갑상어의 양수 발효 조성물의 제조방법, 이로부터 수득되는 철갑상어의 양수 발효 조성물 및 이를 포함하는 화장료 조성물 |
CN104721116A (zh) * | 2015-02-12 | 2015-06-24 | 宝健(北京)生物技术有限公司 | 一种具有抗衰老功效的组合物及其制备方法和应用 |
CN106420404A (zh) * | 2015-08-12 | 2017-02-22 | 科丝美诗(中国)化妆品有限公司 | 具有抗氧化效果的发酵植物性油脂化妆品组合物 |
KR20180018055A (ko) * | 2016-08-12 | 2018-02-21 | 한국국제대학교 산학협력단 | 철갑상어 유래 유용물질을 포함하는 주름개선 화장료 조성물, 그 유용물질의 수득방법과 그 유용물질을 이용한 주름개선 화장품 제조방법 |
CN106361678A (zh) * | 2016-11-10 | 2017-02-01 | 康美氏(厦门)生物科技有限公司 | 一种具有皮肤抗衰老功效的组合物及该组合物在化妆品中的应用 |
CN107536757A (zh) * | 2017-09-15 | 2018-01-05 | 广州赛莱拉干细胞科技股份有限公司 | 一种防止皮肤老化的组合物及含有该组合物的护肤品 |
Non-Patent Citations (3)
Title |
---|
CHIEN-LIANG FANG等: "Dermal Lipogenesis Inhibits Adiponectin Production in Human Dermal Fibroblasts while Exogenous Adiponectin Administration Prevents against UVA-Induced Dermal Matrix Degradation in Human Skin", 《INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES》 * |
任华,等: "鲟鱼营养价值及其精深加工产品市场", 《江西水产科技》 * |
尹靖东: "《动物肌肉生物学与肉品质学》", 31 December 2011, 中国农业大学出版社 * |
Also Published As
Publication number | Publication date |
---|---|
KR20190132705A (ko) | 2019-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6929836B2 (ja) | 植物搾汁物由来の細胞外小胞体を含む皮膚改善および脱毛防止用組成物 | |
CN111053716B (zh) | 一种茯茶提取物在制备皮肤调节产品中的用途 | |
JP4693963B2 (ja) | エストロゲン様作用剤、コラーゲン産生促進剤、及び線維芽細胞増殖剤 | |
TWI500428B (zh) | 不含有糖之鳳梨萃取物、及其製造方法、以及其用途 | |
CN110840812A (zh) | 胎体来源的外泌体在皮肤调节产品中的用途 | |
CN110403890A (zh) | 包括鲟鱼卵提取物和鲟鱼羊水提取物的用于皮肤美容的组合物 | |
CN106999527A (zh) | 用于预防掉发或刺激头发生长的包含伞形花序蒿提取物的组合物 | |
CN106265462B (zh) | 一种组份型祛斑美容霜及制备方法 | |
JP4672269B2 (ja) | 抗老化剤、血小板凝集抑制剤、抗酸化剤、抗アレルギー剤、皮膚化粧料及び飲食品 | |
TW202102239A (zh) | 抗老化劑、抗氧化劑、抗炎症劑、及美白劑、以及化妝品 | |
KR101946114B1 (ko) | 벨루가 렌틸 추출물을 유효성분으로 함유하는 주름 또는 탄력 개선용 조성물 | |
JP4247091B2 (ja) | 皮膚老化防止剤 | |
CN109689026A (zh) | 使用包含生物活性莲(nelumbo nucifera)提取物的组合物增加脂肪分解的方法 | |
KR102106440B1 (ko) | 블루베리 및 흑미 추출물 배양 유산균을 포함하는 피부상태 개선용 조성물 | |
KR102047461B1 (ko) | 앉은 부채 추출물 또는 이의 분획물을 유효성분으로 포함하는 주름 개선용 조성물 | |
KR20220096277A (ko) | 생열귀나무 추출물을 유효성분으로 포함하는 탈모 예방 또는 치료용, 또는 발모 또는 육모 촉진용 조성물 | |
CN107206039A (zh) | 含高山黄芩提取物的用于美白肌肤的组合物 | |
KR20190130543A (ko) | 앉은 부채 추출물 또는 이의 분획물을 유효성분으로 포함하는 주름 개선용 조성물 | |
KR102186984B1 (ko) | 녹나무(樟腦木) 추출물을 함유하는 멜라닌세포 이동 촉진 조성물 | |
JP6288759B2 (ja) | トランスグルタミナーゼ活性化剤 | |
KR101967919B1 (ko) | 누리장나무 추출물의 헥산 분획물 또는 누리장나무 추출물로부터 분리한 화합물을 유효성분으로 함유하는 피부주름의 예방, 개선 또는 치료용 조성물 | |
KR102311011B1 (ko) | 인간지방줄기세포의 증식 촉진용 조성물 | |
KR20180104960A (ko) | 바나나, 체리 및 호두의 혼합 추출물을 포함하는 피부 노화 방지 또는 개선용 조성물 | |
KR20170021607A (ko) | 피부 상태 개선용 조성물 | |
KR102152932B1 (ko) | 카테킨 배당체를 유효 성분으로 함유하는 피부 상태 개선용 조성물 및 이를 이용한 피부 상태 개선 방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20191105 |